Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.

Sigurdsson S, Nordmark G, Göring HH, Lindroos K, Wiman AC, Sturfelt G, Jönsen A, Rantapää-Dahlqvist S, Möller B, Kere J, Koskenmies S, Widén E, Eloranta ML, Julkunen H, Kristjansdottir H, Steinsson K, Alm G, Rönnblom L, Syvänen AC.

Am J Hum Genet. 2005 Mar;76(3):528-37.

2.

Evidence for genetic association and interaction between the TYK2 and IRF5 genes in systemic lupus erythematosus.

Hellquist A, Järvinen TM, Koskenmies S, Zucchelli M, Orsmark-Pietras C, Berglind L, Panelius J, Hasan T, Julkunen H, D'Amato M, Saarialho-Kere U, Kere J.

J Rheumatol. 2009 Aug;36(8):1631-8. doi: 10.3899/jrheum.081160.

PMID:
19567624
3.

Association of IRF5 polymorphisms with systemic lupus erythematosus in a Japanese population: support for a crucial role of intron 1 polymorphisms.

Kawasaki A, Kyogoku C, Ohashi J, Miyashita R, Hikami K, Kusaoi M, Tokunaga K, Takasaki Y, Hashimoto H, Behrens TW, Tsuchiya N.

Arthritis Rheum. 2008 Mar;58(3):826-34. doi: 10.1002/art.23216.

4.

Genetic association and interaction between the IRF5 and TYK2 genes and systemic lupus erythematosus in the Han Chinese population.

Tang L, Wan P, Wang Y, Pan J, Wang Y, Chen B.

Inflamm Res. 2015 Oct;64(10):817-24. doi: 10.1007/s00011-015-0865-2.

PMID:
26294277
5.

Tyrosine kinase 2 and interferon regulatory factor 5 polymorphisms are associated with discoid and subacute cutaneous lupus erythematosus.

Järvinen TM, Hellquist A, Koskenmies S, Einarsdottir E, Koskinen LL, Jeskanen L, Berglind L, Panelius J, Hasan T, Ranki A, Kere J, Saarialho-Kere U.

Exp Dermatol. 2010 Feb;19(2):123-31. doi: 10.1111/j.1600-0625.2009.00982.x.

6.

Association of polymorphisms across the tyrosine kinase gene, TYK2 in UK SLE families.

Cunninghame Graham DS, Akil M, Vyse TJ.

Rheumatology (Oxford). 2007 Jun;46(6):927-30.

7.

Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.

Sigurdsson S, Göring HH, Kristjansdottir G, Milani L, Nordmark G, Sandling JK, Eloranta ML, Feng D, Sangster-Guity N, Gunnarsson I, Svenungsson E, Sturfelt G, Jönsen A, Truedsson L, Barnes BJ, Alm G, Rönnblom L, Syvänen AC.

Hum Mol Genet. 2008 Mar 15;17(6):872-81.

8.

Association of a common interferon regulatory factor 5 (IRF5) variant with increased risk of systemic lupus erythematosus (SLE).

Demirci FY, Manzi S, Ramsey-Goldman R, Minster RL, Kenney M, Shaw PS, Dunlop-Thomas CM, Kao AH, Rhew E, Bontempo F, Kammerer C, Kamboh MI.

Ann Hum Genet. 2007 May;71(Pt 3):308-11.

9.

Replication of GWAS-identified systemic lupus erythematosus susceptibility genes affirms B-cell receptor pathway signalling and strengthens the role of IRF5 in disease susceptibility in a Northern European population.

Järvinen TM, Hellquist A, Zucchelli M, Koskenmies S, Panelius J, Hasan T, Julkunen H, D'Amato M, Kere J.

Rheumatology (Oxford). 2012 Jan;51(1):87-92. doi: 10.1093/rheumatology/ker263. Review.

10.

Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations.

Kristjansdottir G, Sandling JK, Bonetti A, Roos IM, Milani L, Wang C, Gustafsdottir SM, Sigurdsson S, Lundmark A, Tienari PJ, Koivisto K, Elovaara I, Pirttilä T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fernández O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syvänen AC.

J Med Genet. 2008 Jun;45(6):362-9. doi: 10.1136/jmg.2007.055012.

11.

A redundant epistatic interaction between IRF5 and STAT4 of the type I interferon pathway in susceptibility to lupus and rheumatoid arthritis.

Kim K, Cho SK, Han TU, Kim JH, Kang SJ, Kang C, Bae SC.

Lupus. 2013 Nov;22(13):1336-40. doi: 10.1177/0961203313504479.

PMID:
24014567
12.

A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans.

Prokunina L, Castillejo-López C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdóttir H, Gröndal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jönssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcón-Segovia D, Steinsson K, Alarcón-Riquelme ME.

Nat Genet. 2002 Dec;32(4):666-9.

PMID:
12402038
13.

The potential role of interferon-regulatory factor 7 among Taiwanese patients with systemic lupus erythematosus.

Lin LH, Ling P, Liu MF.

J Rheumatol. 2011 Sep;38(9):1914-9. doi: 10.3899/jrheum.101004.

PMID:
21632682
14.

A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles.

Budarf ML, Goyette P, Boucher G, Lian J, Graham RR, Claudio JO, Hudson T, Gladman D, Clarke AE, Pope JE, Peschken C, Smith CD, Hanly J, Rich E, Boire G, Barr SG, Zummer M; GenES Investigators., Fortin PR, Wither J, Rioux JD.

Genes Immun. 2011 Jan;12(1):51-8. doi: 10.1038/gene.2010.47.

PMID:
20962850
15.

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.

Graham RR, Kozyrev SV, Baechler EC, Reddy MV, Plenge RM, Bauer JW, Ortmann WA, Koeuth T, González Escribano MF; Argentine and Spanish Collaborative Groups., Pons-Estel B, Petri M, Daly M, Gregersen PK, Martín J, Altshuler D, Behrens TW, Alarcón-Riquelme ME.

Nat Genet. 2006 May;38(5):550-5.

PMID:
16642019
16.

Genetic linkage and association of Fcgamma receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus.

Edberg JC, Langefeld CD, Wu J, Moser KL, Kaufman KM, Kelly J, Bansal V, Brown WM, Salmon JE, Rich SS, Harley JB, Kimberly RP.

Arthritis Rheum. 2002 Aug;46(8):2132-40.

17.

Identification of novel susceptibility genes in childhood-onset systemic lupus erythematosus using a uniquely designed candidate gene pathway platform.

Jacob CO, Reiff A, Armstrong DL, Myones BL, Silverman E, Klein-Gitelman M, McCurdy D, Wagner-Weiner L, Nocton JJ, Solomon A, Zidovetzki R.

Arthritis Rheum. 2007 Dec;56(12):4164-73.

18.

Opposed independent effects and epistasis in the complex association of IRF5 to SLE.

Ferreiro-Neira I, Calaza M, Alonso-Perez E, Marchini M, Scorza R, Sebastiani GD, Blanco FJ, Rego I, Pullmann R Jr, Pullmann R, Kallenberg CG, Bijl M, Skopouli FN, Mavromati M, Migliaresi S, Barizzone N, Ruzickova S, Dostal C, Schmidt RE, Witte T, Papasteriades C, Kappou-Rigatou I, Endreffy E, Kovacs A, Ordi-Ros J, Balada E, Carreira P, Gomez-Reino JJ, Gonzalez A.

Genes Immun. 2007 Jul;8(5):429-38.

PMID:
17568788
19.

A compass that points to lupus: genetic studies on type I interferon pathway.

Kyogoku C, Tsuchiya N.

Genes Immun. 2007 Sep;8(6):445-55. Review.

PMID:
17581625
20.

Genome-wide profiling of target genes for the systemic lupus erythematosus-associated transcription factors IRF5 and STAT4.

Wang C, Sandling JK, Hagberg N, Berggren O, Sigurdsson S, Karlberg O, Rönnblom L, Eloranta ML, Syvänen AC.

Ann Rheum Dis. 2013 Jan;72(1):96-103. doi: 10.1136/annrheumdis-2012-201364.

PMID:
22730365
Items per page

Supplemental Content

Support Center